CANCER RESEARCH TECHNOLOGY LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 90165
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7193
 
  
 
C07K PEPTIDES 31105
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 20186
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13154
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1283
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1039
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7118
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0016,274 AUTOTAXIN INHIBITORY COMPOUNDSFeb 04, 16Jan 18, 18[A61K, C07D]
2017/0267,675 INDAZOLESJul 30, 15Sep 21, 17[A61K, C07D]
2017/0204,455 Method for Detecting a Genetic VariantJul 17, 15Jul 20, 17[C12Q, G06F]
2017/0121,418 CD55-INTERACTION PARTNERS AND THE USES THEREOFJan 12, 17May 04, 17[A61K, C07K]
2016/0300,010 METHOD AND SYSTEM FOR PREDICTING SELECTIVE CANCER DRUG TARGETSMar 31, 16Oct 13, 16[G06F]
2016/0223,442 BIOLOGICAL FLUID FILTRATION ASSEMBLYSep 12, 14Aug 04, 16[C12Q, C12N, G01N, B01L, A61B, B01D]
2015/0202,249 ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPYDec 18, 14Jul 23, 15[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919023 Anti-androgen peptides and uses thereof in cancer therapyDec 18, 14Mar 20, 18[A61K, C07K]
9914730 Azaquinazoline inhibitors of Atypical protein Kinase CSep 27, 13Mar 13, 18[A61K, C07F, C07D]
9902721 N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitorsFeb 27, 15Feb 27, 18[A61K, A01N, C07D]
9895364 Pharmacologically active compoundsMar 14, 16Feb 20, 18[A61K, C07D]
9896446 Azaquinazoline inhibitors of atypical protein kinase CDec 18, 15Feb 20, 18[A61K, C07F, C07D]
9890157 Inhibitor compoundsApr 06, 16Feb 13, 18[A61K, A01N, C07D]
9862717 IndazolesJul 30, 15Jan 09, 18[A61K, C07D]
9834541 2-aminopyridine compoundsOct 02, 13Dec 05, 17[A61K, C07D]
9834552 Inhibitor compoundsApr 06, 16Dec 05, 17[A61K, A01N, C07D]
9820976 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapySep 01, 16Nov 21, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0355,478 THERAPEUTIC AGENTSAbandonedMay 10, 16Dec 08, 16[A61K, C07D]
2016/0250,187 PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORSAbandonedJan 29, 16Sep 01, 16[A61K]
2016/0208,003 AntibodiesAbandonedAug 25, 15Jul 21, 16[A61K, C07K]
2016/0016,951 NOVEL NAPHTHYRIDINES AND ISOQUINOLINES AND THEIR USE AS CDK8/19 INHIBITORSAbandonedJul 17, 15Jan 21, 16[C07D]
2014/0356,365 PROGNOSTIC, SCREENING AND TREATMENT METHODS AND AGENTS FOR TREATMENT OF METSTASIS AND INFLAMMATION USING T54 ONCOFOETAL GLYCOPROTEINAbandonedApr 10, 14Dec 04, 14[G01N, C07K]
2014/0135,327 N- (2 -AMINOPHENYL) BENZAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORSAbandonedJul 06, 12May 15, 14[C07D, G01N]
2014/0023,589 FRMD4A ANTAGONISTS AND THEIR USESAbandonedFeb 09, 12Jan 23, 14[A61K]
8541461 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulatorsExpiredJun 21, 06Sep 24, 13[A61K]
8394381 Antibodies, polypeptides and uses thereofExpiredMay 05, 06Mar 12, 13[A61K]
8383816 Aryl-quinolyl compounds and their useExpiredApr 27, 09Feb 26, 13[C07D]
2012/0283,956 METHOD AND SYSTEM FOR PREDICTING SELECTIVE CANCER DRUG TARGETSAbandonedMar 02, 12Nov 08, 12[G06F]
2012/0207,755 CANCERAbandonedFeb 17, 12Aug 16, 12[A61K, A61P]
2012/0020,876 HEDGEHOG PATHWAY INHIBITORSAbandonedJan 22, 10Jan 26, 12[A61K, C12N, G01N, A61P]
2011/0280,930 PRODUCTS AND METHODS FOR STIMULATING AN IMMUNE RESPONSEAbandonedMay 05, 09Nov 17, 11[A61K, C12N, A61P, C07K]
2011/0212,116 IMMUNOGENIC PEPTIDES AND USES THEREOFAbandonedOct 01, 09Sep 01, 11[A61K, C07H, C12Q, C12N, A61P, C40B, C07K]
2011/0130,386 DNA-PK INHIBITORSAbandonedApr 24, 09Jun 02, 11[A61K, C07D, C12N, A61P]
7951819 Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compoundsExpiredApr 26, 07May 31, 11[A61K, A01N, C07D]
2011/0098,325 PYRIDINE BENZAMIDES AND PYRAZINE BENZAMIDES USED AS PKD INHIBITORSAbandonedDec 14, 07Apr 28, 11[A61K, C12N, C07D, A61P]
7868039 Anti-cancer combinationsExpiredJul 30, 07Jan 11, 11[A61K, A01N]
7868040 Anti-cancer combinationsExpiredJul 30, 07Jan 11, 11[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.